The World's #1 Mining Property Marketplace

Established 2009 — Connecting Buyers and Sellers Worldwide

Rewind Therapeutics Secures 15.2 M EURO to Develop Novel Remyelination Therapies

LEUVEN, Belgium, January 4, 2018 /PRNewswire/ —
Rewind Therapeutics, a privately held Belgian biotech company, today announced the completion of a €15.2 million Series A financing to develop novel re-myelinating therapies for patients suffering from Multiple Sclerosis and other…